Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19

Ann Intern Med. 2020 May 5;172(9):629-632. doi: 10.7326/M20-0533. Epub 2020 Mar 12.

¹ Center for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (H.Z., Y.W., H.Y., Y.W., S.Z., H.L., J.Z., C.W.).
² CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China (P.Z., Y.C.).
³ Wuhan Pulmonary Hospital, Wuhan, China (M.H., C.Y., M.L., G.G., X.C., P.P., R.D.).
⁴ Pulmonary Hospital, Wuhan, China (T.C.).
⁵ Institution of Tuberculosis for Prevention and Cure, Wuhan Pulmonary Hospital, Wuhan, China (M.L.).

No abstract available

Publication types